Discontinuation report MYLAN-ENALAPRIL
Report ID | 106759 |
Drug Identification Number | 02300052 |
Brand name | MYLAN-ENALAPRIL |
Common or Proper name | ENALAPRIL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ENALAPRIL SODIUM |
Strength(s) | 8MG |
Dosage form(s) | |
Route of administration | |
Packaging size | 100 BT, 500 BT |
ATC code | C09AA |
ATC description | ACE INHIBITORS, PLAIN |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-01-23 |
Remaining supply date | 2020-01-23 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Discontinued in shortage ID 54237. Last lot 3049782-1 exp 2019-12-31 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-02-20 | French | Compare |
v1 | 2020-02-20 | English | Compare |
Showing 1 to 2 of 2